-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EHXE4YFKw/odUUn7Wxjb/Z7wyG0yzYUAR2PnARsVpi+RT+378qJiMwUCZzPAOqct 1pEIPHaJ20K/j+GJc0GWLg== 0001193125-06-031582.txt : 20060214 0001193125-06-031582.hdr.sgml : 20060214 20060214164703 ACCESSION NUMBER: 0001193125-06-031582 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060214 DATE AS OF CHANGE: 20060214 GROUP MEMBERS: ATLAS GLOBAL INVESTMENTS II, LTD. GROUP MEMBERS: ATLAS GLOBAL INVESTMENTS, LTD. GROUP MEMBERS: ATLAS GLOBAL, LLC GROUP MEMBERS: ATLAS MASTER FUND, LTD. GROUP MEMBERS: DMITRY BALYASNY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-51051 FILM NUMBER: 06616277 BUSINESS ADDRESS: STREET 1: 787 SEVENTH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125544555 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BALYASNY ASSET MANAGEMENT LLC CENTRAL INDEX KEY: 0001218710 IRS NUMBER: 364472709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 181 W MADISON STE 3600 CITY: CHICAGO STATE: IL ZIP: 60602 BUSINESS PHONE: 3124992999 MAIL ADDRESS: STREET 1: 181 W MADISON STE 3600 CITY: CHICAGO STATE: IL ZIP: 60602 SC 13G/A 1 dsc13ga.htm SCHEDULE 13G/A SCHEDULE 13G/A

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G/A

 

 

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

 

 

 

 

 

MANHATTAN PHARMACEUTICALS, INC.

(Name of Issuer)

 

 

COMMON STOCK, par value $.001 per share

(Title of Class of Securities)

 

 

563 118 108

(CUSIP Number)

 

 

December 31, 2005

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨  Rule 13d-1(b)

 

x Rule 13d-1(c)

 

¨  Rule 13d-1(d)

 

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 563 118 108    Page 2 of 14 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

 

Atlas Master Fund, Ltd.

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

 

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

Cayman Islands

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5      SOLE VOTING POWER

 

 

        2,824,261 (See Item 4)

 

  6      SHARED VOTING POWER

 

 

        None

 

  7      SOLE DISPOSITIVE POWER

 

 

        2,824,261 (See Item 4)

 

  8      SHARED DISPOSITIVE POWER

 

 

        None

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

2,824,261 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

¨

 

Not Applicable

    
11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

 

3.19%

    
12  

TYPE OF REPORTING PERSON*

 

 

CO

    

 

*SEE INSTRUCTIONS BEFORE FILLING OUT.

CUSIP No. 563 118 108    Page 3 of 14 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

 

Atlas Global, LLC

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

 

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

Delaware

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5      SOLE VOTING POWER

 

 

        None

 

  6      SHARED VOTING POWER

 

 

        2,824,261 (See Item 4)

 

  7      SOLE DISPOSITIVE POWER

 

 

        None

 

  8      SHARED DISPOSITIVE POWER

 

 

        2,824,261 (See Item 4)

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

2,824,261 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

¨

 

Not Applicable

    
11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

 

3.19%

    
12  

TYPE OF REPORTING PERSON*

 

 

OO

    

 

*SEE INSTRUCTIONS BEFORE FILLING OUT.

CUSIP No. 563 118 108    Page 4 of 14 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

 

Atlas Global Investments, Ltd.

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

 

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

Cayman Islands

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5      SOLE VOTING POWER

 

 

        None

 

  6      SHARED VOTING POWER

 

 

        2,824,261 (See Item 4)

 

  7      SOLE DISPOSITIVE POWER

 

 

        None

 

  8      SHARED DISPOSITIVE POWER

 

 

        2,824,261 (See Item 4)

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

2,824,261 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

¨

 

Not Applicable

    
11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

 

3.19%

    
12  

TYPE OF REPORTING PERSON*

 

 

CO

    

 

*SEE INSTRUCTIONS BEFORE FILLING OUT.

CUSIP No. 563 118 108    Page 5 of 14 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

 

Atlas Global Investments II, Ltd.

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

 

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

Cayman Islands

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5      SOLE VOTING POWER

 

 

        None

 

  6      SHARED VOTING POWER

 

 

        2,824,261 (See Item 4)

 

  7      SOLE DISPOSITIVE POWER

 

 

        None

 

  8      SHARED DISPOSITIVE POWER

 

 

        2,824,261 (See Item 4)

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

2,824,261 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

¨

 

Not Applicable

    
11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

 

3.19%

    
12  

TYPE OF REPORTING PERSON*

 

 

CO

    

 

*SEE INSTRUCTIONS BEFORE FILLING OUT.

CUSIP No. 563 118 108    Page 6 of 14 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

 

Balyasny Asset Management L.P.

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

 

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

Delaware

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5      SOLE VOTING POWER

 

 

        2,824,261 (See Item 4)

 

  6      SHARED VOTING POWER

 

 

        None

 

  7      SOLE DISPOSITIVE POWER

 

 

        2,824,261 (See Item 4)

 

  8      SHARED DISPOSITIVE POWER

 

 

        None

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

2,824,261 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

¨

 

Not Applicable

    
11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

 

3.19%

    
12  

TYPE OF REPORTING PERSON*

 

 

OO

    

 

*SEE INSTRUCTIONS BEFORE FILLING OUT.

CUSIP No. 563 118 108    Page 7 of 14 Pages

 

  1  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

 

Dmitry Balyasny

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  ¨

    
  3  

SEC USE ONLY

 

 

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

United States

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5      SOLE VOTING POWER

 

 

        2,824,261 (See Item 4)

 

  6      SHARED VOTING POWER

 

 

        None

 

  7      SOLE DISPOSITIVE POWER

 

 

        2,824,261 (See Item 4)

 

  8      SHARED DISPOSITIVE POWER

 

 

        None

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

2,824,261 (See Item 4)

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

¨

 

Not Applicable

    
11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

 

3.19%

    
12  

TYPE OF REPORTING PERSON*

 

 

IN

    

 

*SEE INSTRUCTIONS BEFORE FILLING OUT.

Item 1   

(a)    Name of Issuer:

    

Manhattan Pharmaceuticals, Inc. (the “Company”)

    

(b)    Address of Issuer’s Principal Executive Offices:

    

787 Seventh Avenue, 48th Floor

    

New York, NY 10019

Item 2    (a) – (c) This statement is filed on behalf of the following:
    

(1) Atlas Master Fund, Ltd., a Cayman Islands corporation (“AMF”), with its principal business office at c/o Walkers SPV Limited, Walker House, P.O. Box 908 GT, George Town, Grand Cayman, Cayman Islands, British West Indies.

    

(2) Atlas Global, LLC, a Delaware limited liability company (“AG”), with its principal business office at 181 West Madison, Suite 3600, Chicago, IL 60602. AG owns 20.39% of the equity interests in AMF.

    

(3) Atlas Global Investments, Ltd., a Cayman Islands corporation (“AGI1”), with its principal business office at c/o Walkers SPV Limited, Walker House, P.O. Box 908 GT, George Town, Grand Cayman, Cayman Islands, British West Indies. AGI1 owns 71.19% of the equity interests in AMF.

    

(4) Atlas Global Investments II, Ltd., a Cayman Islands corporation (“AGI2”), with its principal business office at c/o Walkers SPV Limited, Walker House, P.O. Box 908 GT, George Town, Grand Cayman, Cayman Islands, British West Indies. AGI2 owns 8.42% of the equity interests in AMF.

    

(5) Balyasny Asset Management L.P., a Delaware limited partnership (“BAM”), with its principal business office at 181 West Madison, Suite 3600, Chicago, IL 60602. BAM is the sole managing member of AG and is the investment manager to each of AG, AGI1 and AGI2.

    

(6) Dmitry Balyasny, a United States citizen whose business address is 181 West Madison, Suite 3600, Chicago, IL 60602. Dmitry Balyasny is the sole managing member of the general partner of BAM.

    

(d)    Title of Class of Securities:

    

Common Stock, par value $.001 per share

    

(e)    CUSIP Number: 563 118 108

 

Page 8 of 14 Pages

Item 3    If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
     Not Applicable
Item 4    Ownership:
     AMF
    

(a)    Amount Beneficially Owned:

    

2,824,261 shares

    

(b)    Percent of Class:

    

3.19%

    

(c)    Number of Shares as to which person has:

    

(i)      sole power to vote or to direct vote:

    

2,824,261 shares

    

(ii)     shared power to vote or to direct vote:

    

None

    

(iii)   sole power to dispose or direct disposition of:

    

2,824,261 shares

    

(iv)    shared power to dispose or to direct disposition of:

    

None

    

AG

    

(a)    Amount Beneficially Owned:

    

By virtue of its ownership of 20.39% of the equity interest in AMF, AG may be deemed to beneficially own the 2,824,261 shares of the Company’s Common Stock beneficially owned by AMF.

 

Page 9 of 14 Pages

    

(b)    Percent of Class:

    

3.19%

    

(c)    Number of Shares as to which person has:

    

(i)      sole power to vote or to direct vote:

    

None

    

(ii)     shared power to vote or to direct vote:

    

2,824,261 shares

    

(iii)   sole power to dispose or direct disposition of:

    

None

    

(iv)    shared power to dispose or to direct disposition of:

    

2,824,261 shares

     AGI1
    

(a)    Amount Beneficially Owned:

    

By virtue of its ownership of 71.19% of the equity interest in AMF, AGI1 may be deemed to beneficially own the 2,824,261 shares of the Company’s Common Stock beneficially owned by AMF.

    

(b)    Percent of Class:

    

3.19%

    

(c)    Number of Shares as to which person has:

    

(i)      sole power to vote or to direct vote:

    

None

    

(ii)     shared power to vote or to direct vote:

    

2,824,261 shares

 

Page 10 of 14 Pages

    

(iii)    sole power to dispose or direct disposition of:

    

None

    

(iv)    shared power to dispose or to direct disposition of:

    

2,824,261 shares

     AGI2
    

(a)    Amount Beneficially Owned:

    

By virtue of its ownership of 8.42% of the equity interest in AMF, AGI2 may be deemed to beneficially own the 2,824,261 shares of the Company’s Common Stock beneficially owned by AMF.

    

(b)    Percent of Class:

    

3.19%

    

(c)    Number of Shares as to which person has:

    

(i)      sole power to vote or to direct vote:

    

None

    

(ii)     shared power to vote or to direct vote:

    

2,824,261 shares

    

(iii)   sole power to dispose or direct disposition of:

    

None

    

(iv)    shared power to dispose or to direct disposition of:

    

2,824,261 shares

     BAM
    

(a)    Amount Beneficially Owned:

    

By virtue of its position as investment manager of each of AG, AGI1 and AGI2 and its role as sole managing member of AG, BAM may be deemed to beneficially own the 2,824,261 shares of the Company’s Common Stock beneficially owned by AG, AGI1 and AGI2.

 

Page 11 of 14 Pages

    

(b)    Percent of Class:

    

3.19%

    

(c)    Number of Shares as to which person has:

    

(i)      sole power to vote or to direct vote:

    

2,824,261 shares

    

(ii)     shared power to vote or to direct vote:

    

None

    

(iii)   sole power to dispose or direct disposition of:

    

2,824,261 shares

    

(iv)    shared power to dispose or to direct disposition of:

    

None

     Dmitry Balyasny
    

(a)    Amount Beneficially Owned:

    

By virtue of his position as the sole managing member of the general partner of BAM, Mr. Balyasny may be deemed to beneficially own the 2,824,261 shares of the Company’s Common Stock beneficially owned by BAM.

    

(b)    Percent of Class:

    

3.19%

    

(c)    Number of Shares as to which person has:

    

(i)      sole power to vote or to direct vote:

    

2,824,261 shares

    

(ii)     shared power to vote or to direct vote:

    

None

 

Page 12 of 14 Pages

   

(iii)   sole power to dispose or direct disposition of:

   

2,824,261 shares

   

(iv)    shared power to dispose or to direct disposition of:

   

None

Item 5   Ownership of Five Percent or Less of a Class:
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following x.
Item 6   Ownership of More than Five Percent on Behalf of Another Person:
    Not Applicable
Item 7   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
    Not Applicable
Item 8   Identification and Classification of Members of the Group:
    Not Applicable
Item 9   Notice of Dissolution of Group:
    Not Applicable
Item 10   Certification:
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Page 13 of 14 Pages

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: February 10, 2006.

 

ATLAS MASTER FUND, LTD.       ATLAS GLOBAL INVESTMENTS II, LTD.
By:  

/S/ Dmitry Balyasny

      

By:

  

/S/ Dmitry Balyasny

   

Authorized Signatory

          

Dmitry Balyasny

Authorized Signatory

ATLAS GLOBAL, LLC       BALYASNY ASSET MANAGEMENT L.P.

By:

  

/S/ Dmitry Balyasny

      

By:

  

/S/ Dmitry Balyasny

   

Dmitry Balyasny

Authorized Signatory

          

Dmitry Balyasny

Authorized Signatory

ATLAS GLOBAL INVESTMENTS, LTD.        

By:

  

/S/ Dmitry Balyasny

      

By:

  

/S/ Dmitry Balyasny

   

Authorized Signatory

          

Dmitry Balyasny

 

Page 14 of 14 Pages

-----END PRIVACY-ENHANCED MESSAGE-----